Dn B Asset Management As Biomarin Pharmaceutical Inc Transaction History

Dn B Asset Management As

$21.2 Billion
Q1 2025

A detailed history of Dn B Asset Management As transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Dn B Asset Management As holds 991,486 shares of BMRN stock, worth $56.6 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

991,486

Previous 993,170 0.17%

Holding current value

$56.6 Million

Previous $65.3 Million 7.36%

% of portfolio

0.33%

Previous 0.29%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$61.25 - $72.83 $103,145 - $122,645	-1,684 Reduced 0.17%	991,486 $70.1 Million
Q4 2024 Feb 12, 2025	SELL	$61.93 - $70.49 $5.04 Million - $5.74 Million	-81,458 Reduced 7.58%	993,170 $65.3 Million
Q3 2024 Nov 12, 2024	BUY	$69.02 - $93.84 $3.7 Million - $5.03 Million	53,574 Added 5.25%	1,074,628 $75.5 Million
Q2 2024 Jul 05, 2024	BUY	$74.43 - $92.22 $11.5 Million - $14.2 Million	153,867 Added 17.74%	1,021,054 $84.1 Million
Q1 2024 Apr 12, 2024	BUY	$83.81 - $99.0 $10.2 Million - $12 Million	121,672 Added 16.32%	867,187 $75.7 Million
Q4 2023 Jan 04, 2024	SELL	$76.22 - $98.51 $8.47 Million - $10.9 Million	-111,156 Reduced 12.98%	745,515 $71.9 Million
Q3 2023 Oct 13, 2023	BUY	$85.07 - $94.48 $14.3 Million - $15.9 Million	168,106 Added 24.41%	856,671 $75.8 Million
Q2 2023 Jul 06, 2023	BUY	$86.68 - $100.3 $6.1 Million - $7.05 Million	70,318 Added 11.37%	688,565 $59.7 Million
Q1 2023 Apr 20, 2023	BUY	$87.74 - $117.27 $12.8 Million - $17.2 Million	146,276 Added 30.99%	618,247 $60.1 Million
Q4 2022 Jan 12, 2023	BUY	$80.93 - $108.63 $28.4 Million - $38.1 Million	351,136 Added 290.59%	471,971 $48.8 Billion
Q3 2022 Oct 11, 2022	SELL	$82.16 - $96.94 $4.14 Million - $4.88 Million	-50,351 Reduced 29.41%	120,835 $10.2 Million
Q2 2022 Jul 08, 2022	SELL	$71.48 - $86.85 $218,014 - $264,892	-3,050 Reduced 1.75%	171,186 $14.2 Billion
Q1 2022 Apr 08, 2022	BUY	$74.28 - $92.69 $426,664 - $532,411	5,744 Added 3.41%	174,236 $13.4 Million
Q4 2021 Jan 12, 2022	BUY	$71.72 - $91.47 $1.6 Million - $2.03 Million	22,246 Added 15.21%	168,492 $14.9 Million
Q3 2021 Oct 15, 2021	BUY	$74.77 - $85.47 $1.64 Million - $1.87 Million	21,898 Added 17.61%	146,246 $11.3 Million
Q2 2021 Jul 06, 2021	BUY	$75.51 - $84.79 $4.24 Million - $4.77 Million	56,201 Added 82.47%	124,348 $10.4 Billion
Q1 2021 Apr 15, 2021	BUY	$74.73 - $90.69 $724,881 - $879,693	9,700 Added 16.6%	68,147 $5.15 Million
Q4 2020 Jan 19, 2021	BUY	$72.61 - $90.2 $1.88 Million - $2.34 Million	25,887 Added 79.51%	58,447 $5.13 Million
Q3 2020 Oct 14, 2020	SELL	$71.87 - $131.03 $5.23 Million - $9.54 Million	-72,807 Reduced 69.1%	32,560 $2.48 Million
Q2 2020 Jul 08, 2020	BUY	$79.55 - $124.22 $1.16 Million - $1.81 Million	14,576 Added 16.05%	105,367 $13 Billion
Q1 2020 Apr 17, 2020	SELL	$71.37 - $96.85 $216,393 - $293,649	-3,032 Reduced 3.23%	90,791 $7.67 Million
Q4 2019 Jan 13, 2020	BUY	$64.27 - $86.37 $4.85 Million - $6.52 Million	75,480 Added 411.49%	93,823 $7.93 Million
Q3 2019 Oct 16, 2019	BUY	$67.4 - $85.11 $101,774 - $128,516	1,510 Added 8.97%	18,343 $1.24 Million
Q2 2019 Jul 08, 2019	SELL	$80.35 - $93.9 $125,024 - $146,108	-1,556 Reduced 8.46%	16,833 $0
Q1 2019 Apr 11, 2019	SELL	$84.2 - $98.62 $175,136 - $205,129	-2,080 Reduced 10.16%	18,389 $0
Q4 2018 Jan 15, 2019	SELL	$80.14 - $106.07 $106,666 - $141,179	-1,331 Reduced 6.11%	20,469 $1.74 Million
Q3 2018 Oct 10, 2018	BUY	$93.92 - $105.72 $93,920 - $105,720	1,000 Added 4.81%	21,800 $0
Q2 2018 Jul 06, 2018	BUY	$76.01 - $99.03 $60,808 - $79,224	800 Added 4.0%	20,800 $0
Q1 2018 Apr 11, 2018	BUY	$77.67 - $92.63 $132,039 - $157,471	1,700 Added 9.29%	20,000 $0
Q3 2017 Oct 11, 2017	BUY	$80.6 - $94.95 $1.47 Million - $1.74 Million	18,300	18,300 $0

Others Institutions Holding BMRN

# of Institutions

669

Shares Held

184M

Call Options Held

1.24M

Put Options Held

957K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.6B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Account

Dn B Asset Management As Biomarin Pharmaceutical Inc Transaction History